Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Aeglea BioTherapeutics, Inc. (AGLE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/28/2023 |
SC 13G
| Polar Capital Holdings Plc reports a 5% stake in AEGLEA BIOTHERAPEUTICS, INC. |
| 07/18/2023 |
SC 13G
| Logos Global Management LP reports a 8.1% stake in Aeglea Biotherapeutics, Inc. |
| 07/10/2023 |
SC 13G
| Venrock Healthcare Capital Partners III, L.P. reports a 10% stake in Aeglea BioTherapeutics, Inc. |
| 07/03/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/30/2023 |
SC 13G
| EcoR1 Capital Fund Qualified, L.P. reports a 6.4% stake in Aeglea Biotherapeutics, Inc. |
| 06/30/2023 |
SC 13G
| Deep Track Capital, LP reports a 10% stake in AEGLEA BIOTHERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G
| BAKER BROS. ADVISORS LP reports a 9.9% stake in Aeglea BioTherapeutics, Inc. |
| 02/14/2023 |
SC 13G
| Rock Springs Capital Management LP reports a 5.6% stake in AEGLEA BIOTHERAPEUTICS, INC. |
| 02/03/2023 |
SC 13G
| PICTET ASSET MANAGEMENT SA reports a 0% stake in Aeglea Biotherapeutics Inc. |
| 12/01/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 5.7% stake in AEGLEA BIOTHERAPEUTICS, INC. |
| 02/10/2022 |
SC 13G
| PICTET ASSET MANAGEMENT SA reports a 5% stake in Aeglea Biotherapeutics Inc. |
| 12/16/2021 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 5.2% stake in Aeglea BioTherapeutics, Inc. |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/26/2020 |
SC 13G
| Point72 Asset Management, L.P. reports a 6.2% stake in Aeglea Biotherapeutics, Inc. |
| 06/09/2020 |
SC 13G
| BCLS II Equity Opportunities, LP reports a 6.1% stake in Aeglea BioTherapeutics, Inc. |
| 02/07/2019 |
SC 13G
| BlackRock Inc. reports a 5.4% stake in Aeglea BioTherapeutics, Inc. |
| 10/11/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/08/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/09/2016 |
SC 13G
| Aeglea BioTherapeutics, Inc. reports a 10.7% stake in Aeglea BioTherapeutics Inc. |
| 04/18/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 04/14/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|